Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Antoine

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Urology|May 1, 1999
Conformal proton therapy for early-stage prostate cancerJ D Slater, C J Rossi, L T Yonemoto, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II studyL T Yonemoto, J D Slater, C J Rossi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Conformal proton therapy for prostate carcinomaJ D Slater, L T Yonemoto, C J Rossi, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Urology|May 1, 1999
Conformal proton therapy for early-stage prostate cancerJ D Slater, C J Rossi, L T Yonemoto, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1997
Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II studyL T Yonemoto, J D Slater, C J Rossi, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Conformal proton therapy for prostate carcinomaJ D Slater, L T Yonemoto, C J Rossi, et al.
Bone|February 13, 2001
Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorptionS M Violette, W Guan, C Bartlett, et al.
Pageof 8